Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Swiss healthcare market: regulatory environment
Current composition of drug prices (SBR IV)
Fixed margin elements help to offset price reductions
Composition of the price of a prescription/ reimbursable drug: c.3/4 of the retail margin secured by fixed elements.
~8% Per prescription / line
Reimbursed →
-29%
- 24% Retail and
~2/3 Fixed
~ 5% Wholesale
~1/3 Variable
Ex-factory→
~71%
FOPH defines price and margin -
Margin covers wholesale and retail
Ex factory price
(in CHF)
+ surcharge
LOA Retail service fees
Galenica total margin
■Supplier margin
Source:
Note:
1
08/08/22
Swissmedic and company information
FOPH stands for Federal Office of Public Health; sets prices based on basket of nine countries and quality aspects
Based on Company internal figures.
36
+ price-related
surcharge
per pack
0.05-4.99
12.0%
4.00
5.00-10.99
12.0%
8.00
11.00-14.99
12.0%
12.00
15.00-879.99
12.0%
16.00
880.00-2.569.99
7.0%
60.00
From 2.570.00
240.00
LOA: Service based compensation
GALENICAView entire presentation